ABSTRACT. Glucose utilization by the placenta and in-
Surgical procedure. Surgery was carried out on day 21 of ternal parameters. (Pediatr Res 23: [480] [481] [482] [483] 1988) pregnancy under ketamine hydrochloride (35 mg/kg intramuscularly) and xylazine hydrochloride (6 mg/kg intramuscularly) Abbreviations anesthesia. Under sterile conditions maternal vessels were cath-FFA, free fatty acids eterized. Polyvinyl catheters were inserted into one jugular vein 2DG, 2-deo~yl-[l-~H]glucose to allow radioactive tracer infusions and into one femoral artery GU, glucose uptake and one branch of the uterine vein for blood sampling under KB, ketone body conscious, unrestrained conditions (4) . In addition, an intracardiac catheter was advanced to the left ventricle through the right carotid artery to allow blood flow measurements (4) . All catheters were tied in place and tunneled subcutaneously to exit into a plastic cap sutured into place in the interscapular region. CathMetabolic requirements of the gravid uterus have been quan-eters were filled with an heparinized solution (800 IU/ml saline) tified in vivo in the cow (1) and the sheep (2) and more recently and were flushed every 3 days to keep them patent. Detailed in the guinea pig (3) and the rabbit (4) . The growth and oxidative description of the surgical procedures has been reported previmetabolism of the mammalian fetus are largely dependent on ously (4) . the rates of fetal glucose and amino acid utilization (5) . Most of Measurements ofglucose utilization by theplacenta, the uterus, these studies have been carried out using chronic vascular cath-andfetal tissues. Experiments were carried out in vivo on day 29 eterization and measurements of overall substrate uptake by the of gestation in fed and 96-h fasted does. The radioactive 2-fetus and the placenta by means of the Fick principle method-deoxyglucose technique recently adapted to the rat fetus was ology. However, this technique does not permit determination used (9, 10) . Glucose utilization index was determined in indiof substrate utilization by individual tissues of the fetus in small vidual tissues after an intravenous injection of 250 pCi 2DG in mammalian species.
the conscious pregnant rabbits. Maternal arterial blood was In this respect, the rabbit is of interest because: 1) use of the sampled at 1, 3, 5, 10, 15, 20, 40, 60, 80, and 120 min after the radioactive 2-deoxyglucose technique, adapted to rodents (6) can radioactive 2DG injection for the determination of radioactive be coupled to determination of blood flow and venous-arterial 2DG and of glucose concentrations. blood glucose concentration difference across the uterus; 2 )
The 3H-2DG-6-phosphate which accumulates in various tismaternal FFA cross the placenta in this species (7) and can sues cannot be further metabolized and represents an index of potentially replace glucose as fuel for fetal tissues, particularly glucose used inasmuch as any molecule of glucose which enters during maternal fasting when increased amounts of FFA are the cell is phosphorylated before being incorporated into glycotransferred to the fetus (8) . The aim herein was to quantify gen or metabolized through the glycolytic pathway. The accuglucose utilization by individual tissues in the fetal rabbit and to mulation of 3H-2DG-6-phosphate in various tissues was measdetermine the partition of glucose between the myoendome-ured in steady state conditions for blood glucose concentration trium, the placenta, and the fetus in the fed and fasted state. The and glucose utilization rates as described in the adult rat (6) . experiments were performed on day 29 of gestation in chronically
Tissue and blood sampling. Maternal arterial blood was withcatheterized pregnant rabbits.
drawn from the femoral artery just before and 120 min after the 2DG injection. At 120 min, after maternal laparotomy, fetal blood was obtained from axillary vessels under pentobarbital were killed by an overdose of pentobarbital and two fetoplacental units adjacent to the ovaries were rapidly excised and the portion of the uterine horn surrounding one fetus and its placenta was carefully dissected out. The myoendometrium, placenta, and fetus corresponding to each fetoplacental unit were removed and weighed. Uterine, placenta, and individual fetal tissues (hindlimb muscle, diaphragm, heart, liver, brain, skin, and white and brown adipose tissue) were rapidly dissected out. These tissues have very lowfglucose-6-phosphatase activity at this stage of gestation (12, 13) and thus the hydrolysis of 2DG-6-phosphate back to 2DG was considered to be negligible. Determinations of radioactivity in blood samples and measurements of tissue 3H-2DG-6-phosphate content were performed according to the technique described previously in the rat (6, 10) . Determination of the lumped constant for the gravid uterus. The lumped constant that is a correction factor for the discrimination against 2-deoxyglucose in glucose transport and phosphorylation pathways was determined in vivo for one fetoplacental unit (fetus, placenta, and surrounding myoendometrium). It is represented by the difference between maternal and fetal blood radioactive 2DG/glucose specific activity because axillary blood of the fetus represents efferent blood from the uteroplacenta (9) . A primed continuous venous infusion of 2-deo~y-[l-~~C]glucose (0.52 pCi/min) in saline was performed during 60 min to obtain a steady blood 2DG specific activity. Blood samples were then obtained in steady state conditions (9) through the maternal femoral artery and via axillary fetal vessels. The samples were deproteinized and the supernatants were treated as described previously (6) . The ratio of maternal arterial blood I4C-2DG/ glucose to fetal blood '4C-2DG/glucose was found to be 0.81 k 0.04 ( n = 7) and was not significantly altered by fasting: 0.72 k 0.04 ( n = 6).
Calculation of glucose utilization index by various tissues. The glucose utilization index was expressed as 3H-2DG-6-phosphate content of each fetal tissue divided by the integral of the ratio of maternal arterial blood 3H-2DG to glucose over a 120-min period. In the present experiments, the lumped constant of fetal tissues was not determined and the results were expressed as glucose utilization indices rather than glucose utilization rates. For the placenta and myoendometrium, the rates of glucose utilization were calculated by dividing the glucose utilization index by the calculated lumped constant.
Measurement of total glucose uterine uptake. The GU by one fetoplacental unit was measured using the Fick prirqiple methodology and calculated according to the formula: GU (nmol/ min/g) = venous-arterial glucose concentration difference across the uterus (pmol/ml) x uteroplacental blood flow (ml/min/g).
Both variables were measured in steady state conditions in fed and fasted pregnant rabbits. Paired venous and arterial blood samples were drawn simultaneously as described previously (4) . Uteroplacental blood flow was measured in conscious animals using radioactive microspheres labeled with Il3Tin (NEN, Dreleich, W. Germany). Calculations of uterine blood flows were done by the reference sample method (4) .
Biochemical measurements. Blood glucose concentration was determined by the glucose oxidase method (Boehringer, Meylan, France) on blood supernatant deproteinized with Ba(OH)2-ZnS04. Blood ketone body and lactate concentrations were measured on neutralized perchloric acid (6%, w/v) supernatants (14, 15) . Plasma FFA concentrations were measnred by an enzymatic method (NEFA C kit, Biolyon, Lyon, France) (4). Plasma insulin was determined by radioimmunoassay on aliquots of the last blood samples using rabbit insulin as standard (16) .
Statistics. Results are presented as means + SEM. Statistical differences were evaluated using the Student's t test.
RESULTS

Metabolic and hormonal changes induced by maternal fasting.
Maternal, fetal, uteroplacental weights, and blood flow remained unchanged after a maternal fast of 96 h (Table 1) . Changes in fetal and maternal endocrine and metabolic parameters are shown in Table 2 . Maternal fasting for 96 h was associated with a 20% decrease in blood glucose, a 5-fold increase in blood KB concentration and a 2-fold increase in plasma FFA concentration. By contrast, the changes induced by fasting were smaller in the fetuses than in the mothers. Although blood glucose was decreased and ketonemia raised, the differences observed did not reach statistical significance. Fetal plasma FFA concentration was increased 3-fold ( p < 0.01). The permeability of the rabbit placenta to glucose, FFA, and KB was estimated by calculating maternofetal substrate concentration gradients (Fig. 1) . Whereas maternofetal gradients for glucose and FFA were not significantly lowered during maternal fasting, an important decrease of maternofetal KB gradient was observed, suggesting a limited transfer of KB from maternal to fetal circulation. Both fetal and maternal plasma insulin concentrations were markedly decreased by maternal fasting (Table 2) .
Glucose utilization by the fetoplacental unit. The rates of glucose utilization by the placenta, the myoendometrium, and the fetoplacental unit (myoendometrium + placenta + fetus) are shown in Figure 2 . Results are expressed as rates of glucose utilization inasmuch as values obtained for the myoendome- nmol/min/g). After maternal fasting, glucose utilization was significantly decreased (-33%) in the myoendometrium ( p < 0.01) but remained unchanged in the placenta and the fetoplacental unit.
Glucose utilization index in individual fetal tissues. The glucose utilization index of liver and brown adipose tissue (Fig. 3) were significantly decreased in fetuses from fasted mothers ( I 1 -1-0.5 versus 7.2 +-0.5 and 27 +-2.2 versus 7.8 +-1.2 nmol/min/g, respectively). By contrast, the glucose utilization index of fetal muscles (hindlimb, diaphragm, heart), white adipose tissue, skin, and brain was not modified by maternal fasting.
DISCUSSION
The fetoplacental unit is a complex structure composed of the fetus and the placenta attached to the surrounding myoendo- metrium. In a number of mammalian species the gravid uterus is composed of only one fetus and one placenta, and therefore quantitative information concerning a single fetoplacental unit in politocus species such as the rabbit is useful for interspecies comparisons. The results obtained in vivo under physiological conditions indicate that in the rabbit the rate of glucose utilization by the placenta is similar to the rate of glucose utilization by the fetoplacental unit. This suggests that fetal glucose utilization is in the same range as the placental glucose utilization because fetal mass represents 80 to 90% of the total fetoplacental unit mass ( Fig. 2; ' Table 1 ). This study also demonstrates that glucose utilization measured simultaneously in the same animal using two different techniques (radioactive 2-deoxyglucose and Fick principle methodology) gives very similar values. Interspecies comparison indicates that, near the term, the epitheliochorial placenta of the sheep (2) utilizes three to five times more glucose than the hemochorial placenta of man (17) , rat (1 8), and rabbit (Fig. 2) .
A 96-h maternal fast beginning on day 25 of gestation does not decrease glucose utilization rates in the placenta and the fetoplacental unit (Fig. 2) . The absence of effects of maternal fasting on placental blood flow and glucose utilization by the fetoplacental unit seems to be specific for the rabbit because large decreases in placental blood flow and glucose utilization have been observed in rat and sheep (1 8-2 1) . Fetal metabolic response to maternal fasting can be analyzed on the basis of the changes occurring in blood substrate and plasma hormone concentrations in mothers and fetuses ( Table 2 ). The significant decrease in maternal blood glucose was not reflected to the same extent in the fetus, suggesting two hypotheses: I ) an increased placental transport capacity to maintain adequate glucose transfer from maternal to fetal circulation; and/or 2) a rapid adaptation of fetal metabolism (increased liver glycogenolysis and gluconeogenesis) to compensate for a decrease in placental transfer of glucose. The present data do not permit determination of which mechanism is operative, but a premature appearance of fetal liver gluconeogenesis has been shown to occur during maternal fasting in the rabbit (22, 23) . The fall in fetal plasma insulin observed during maternal fasting could be explained by the fact that the fetal pancreas is sensitive to small changes of fetal glucose concentration as demonstrated in vitro (24) and in vivo (25) in the rat and in the sheep (26, 27) . The decrease in fetal plasma insulin during fasting could be subsequently responsible for the premature induction of fetal liver phosphoenolpyruvate carboxykinase, the rate limiting enzyme of gluconeogenesis (22, 23) , and thereby preserve fetal glucose homeostasis.
Another point to stress is the selective transfer of fat-derived substrates across the rabbit placenta. Despite very high KB concentration in maternal plasma, KB were not transported to a large extent from maternal to fetal circulation during maternal fasting (Table 2; Fig. 2) . Thus, in the rabbit, as in the sheep (28) , KB cannot serve as alternative fuels for fetal tissues. This is in contrast to what occurs in the rat where a large amount of KB is transferred to the fetus during maternal fasting (29-3 1) . By contrast, a significant transplacental transfer of FFA occurs during maternal fasting in the rabbit as evidenced by the 3-fold increase in fetal plasma (Table 2 ; Fig. I ). Whether or not FFA was used as an energy source in the fetal rabbit was not determined herein but it has been shown that FFA can be stored as triglycerides in liver and adipose tissue (8, 32, 33) .
Use of the glucose analog, 2DG, permits measurement of glucose utilization by individual fetal tissues in animal species where small size does not allow vascular catheterization in the fetus. In addition, this technique may help to determine whether specific modifications occur in individual fetal tissues during maternal fasting, which may be masked when estimating the overall glucose utilization rate by the fetoplacental unit. In vivo, in the fed state, glucose utilization indices are similar in most fetal tissues studied (hindlimb muscles, diaphragm, white and brown adipose tissue, skin, and brain), i.e. about 25 nmol/min/ g tissue, but differ in the heart (55 nmol/min/g) and the liver (1 1 nmol/min/g). In utero the heart exhibits the highest rate of glucose utilization among fetal tissues similar to the ventricle in the adult rat (34) and rabbit (35) . It is noteworthy that in the fetal rabbit, basal and fasted glucose metabolic indices are 5 to 10 times lower than those measured in the fetal rat (10) . These data further emphasize the species specificity previously pointed out for placental blood flow and glucose utilization rate. The maintenance of a constant glucose utilization index in most fetal tissues after 96 h of maternal fasting is probably due to the fact that fetal blood glucose concentration was not significantly decreased. In addition, these results suggest that most fetal tissues are not affected by hypoinsulinemia when blood glucose concentration remains constant. This is in contrast to data obtained in vivo in the fetal lamb (36) where fetal glucose uptake is correlated with arterial plasma insulin levels and in the fetal rat (10) where the rate of glucose utilization in several fetal tissues is increased by exogenous insulin. During maternal fasting in the rabbit, brown adipose tissue and liver are the only fetal tissues in which glucose utilization indices are significantly decreased. Both tissues possess insulin receptors that can be phosphorylated as early as day 20 of gestation (37) . Thus the decreased glucose utilization observed in these tissues in the presence of fetal hypoinsulinemia in the fetuses of fasted mothers could be interpreted as a sign of a higher insulin sensitivity in comparison to other fetal tissues.
In conclusion, this study has demonstrated that the rabbit fetus maintains a physiological blood glucose level and normal rates of glucose utilization in most tissues after a 96-h maternal fast during late gestation. This suggests that selective and specific adaptations may be set up within the fetoplacental unit to protect the fetus and the placenta from the adverse effects of maternal undernutrition.
